Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TTR | P02766 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10952717 | 0.84 | CYP2C19 (0.44) | CYP2C19ALDH1A1CYP2D6HSD17B10ESR2 | |
| SCHEMBL14804859 | 0.83 | TSHR (0.44) | ALDH1A1GAASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL31328395 | 0.82 | CYP2C19 (0.50) | CYP2C19ALDH1A1CYP2D6HSD17B10GAA | |
| SCHEMBL5696503 | 0.82 | SMN1; SMN2 (0.47) | CYP2C19ALDH1A1CYP2D6HSD17B10GAA | |
| SCHEMBL872854 | 0.81 | CYP2C19 (0.46) | CYP2C19ALDH1A1CYP2D6HSD17B10ESR2 | |
| SCHEMBL15119902 | 0.81 | ALDH1A1 (0.42) | CYP2C19ALDH1A1CYP2D6HSD17B10ESR2 | |
| SCHEMBL12197913 | 0.81 | KMT2A (0.54) | ALDH1A1HIF1AKMT2AMEN1CYP1A2 | |
| SCHEMBL12197912 | 0.81 | SLC6A4 (0.39) | CYP2C19ALDH1A1CYP2D6GAASMN1; SMN2 | |
| SCHEMBL10970776 | 0.79 | CYP2C19 (0.41) | CYP2C19ALDH1A1CYP2D6HSD17B10ESR2 | |
| SCHEMBL6277129 | 0.79 | TAAR1 (0.43) | CYP2C19ALDH1A1CYP2D6HSD17B10ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | claimed |
| CN-110144139-A | A kind of zinc oxide base nano particle ink and photoelectric device | 纳晶科技股份有限公司 | 2019-08-20 | — | — | CN | claimed |
| EP-0266161-B1 | LIQUID ORGANIC PEROXIDE COMPOSITIONS | AUSIMONT S.p.A. (IT) | 1992-01-22 | — | — | EP | claimed |
| JP-3191796-A | — | — | None | — | — | JP | disclosed |
| JP-1311043-A | — | — | None | — | — | JP | disclosed |
| CN-112955250-B | Method and device for carrying out chemical reactions under elevated pressure | 巴斯夫欧洲公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-109482368-B | Preparation method and using equipment of ultrasonic pretreatment coal slime flotation reagent | 华北理工大学 | 2024-05-28 | — | — | CN | disclosed |
| US-11850578-B2 | Method and apparatus for performing a chemical reaction under elevated pressure | BASF SE (DE) | 2023-12-26 | — | — | US | disclosed |
| US-11724990-B2 | Kv7 channel activators compositions and methods of use | BIOHAVEN THERAPEUTICS LTD. (VG) | 2023-08-15 | — | — | US | disclosed |
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20210322941-A1 | METHOD AND APPARATUS FOR PERFORMING A CHEMICAL REACTION UNDER ELEVATED PRESSURE | BASF SE (DE) | 2021-10-21 | — | — | US | disclosed |
| US-5298564-A | Crosslinker is 2,4-diphenyl-4-methyl-1-pentene | NIPPON OIL & FATS CO., LTD. (JP) | 1994-03-29 | — | — | US | disclosed |
| EP-0453204-A1 | Composition for cross-linking of ethylene-polymer, method for cross-linking ethylene-polymer, and cross-linkable composition | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-10-23 | — | — | EP | disclosed |
| JP-H03191796-A | PRODUCTION OF OPTICALLY ACTIVE 1-PARA-ISOBUTYLPHENYLETHANOL AND ITS CARBOXYLIC ACID ESTER | DAICEL CHEM IND LTD | 1991-08-21 | — | — | JP | disclosed |
| JP-H01311043-A | PROCESS FOR RECYCING CATALYST IN CARBONYLATION OF ISOBUTYLPHENYL ETHANOL INTO IBUPROFEN | HOECHST CELANESE CORP | 1989-12-15 | — | — | JP | disclosed |
| EP-0337803-A1 | Catalyst recycle in the carbonylation of isobutylphenylethanol to ibuprofen | HOECHST CELANESE CORPORATION (US) | 1989-10-18 | — | — | EP | disclosed |
| EP-0337803-A1 | Catalyst recycle in the carbonylation of isobutylphenylethanol to ibuprofen | HOECHST CELANESE CORPORATION (US) | 1989-10-18 | — | — | EP | disclosed |
| EP-0337803-A1 | Catalyst recycle in the carbonylation of isobutylphenylethanol to ibuprofen | HOECHST CELANESE CORPORATION (US) | 1989-10-18 | — | — | EP | disclosed |
| US-4601797-A | Electrochemical carboxylation of p-isobutylacetophenone and other aryl ketones | MONSANTO COMPANY (US) | 1986-07-22 | — | — | US | disclosed |
| US-4582577-A | Electrochemical carboxylation of p-isobutylacetophenone | MONSANTO COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11724990-B2 | Kv7 channel activators compositions and methods of use | KCNA7, KCNK17, KCNAB1 | CYP2C19 2758/4885ALDH1A1 3093/4885CYP2D6 2826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.